UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032721
Receipt number R000037311
Scientific Title Effect of cardiac rehabilitation on the exercise function in patients after the Fontan operation
Date of disclosure of the study information 2018/05/25
Last modified on 2022/11/28 09:37:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of cardiac rehabilitation on the exercise function in patients after the Fontan operation

Acronym

Cardiac rehabilitation in patients after the Fontan operation

Scientific Title

Effect of cardiac rehabilitation on the exercise function in patients after the Fontan operation

Scientific Title:Acronym

Cardiac rehabilitation in patients after the Fontan operation

Region

Japan


Condition

Condition

Patients after the Fontan operation

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the efficacy of exercise therapy(cardiac rehabilitation) in patients after the Fontan operation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The achievement rate to the plan of exercise therapy

Key secondary outcomes

Exercise tolerance, Quality of life, Muscular strength


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

Carry out 5-20 minutes ergometer exercises, supervised by doctors and physiotherapists. Training intensity is set under the load at the anaerobic threshold determined by cardiopulmonary exercise testing. Total exercise duration is 1-3 times weekly for 10-12 wekks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) A patient with a Fontan circulation who meets the criteria of exercise therapy (cardiac rehabilitation) by health insurance
2) Height above 140cm
3) A patient who is not prohibited from exercising by doctors
4) A patient who is willing to participate in a training program, and able to give informed consent to participation

Key exclusion criteria

A patient who correspond to contraindication to exercise therapy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name MUNEAKI
Middle name
Last name MATSUBARA

Organization

Faculty of Medicine, University of Tsukuba

Division name

Department of Cardiovascular Surgery

Zip code

3058575

Address

1-1-1 Tennodai, Tsukuba, Ibaraki

TEL

029-853-3210

Email

matsubaram@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name MUNEAKI
Middle name
Last name MATSUBARA

Organization

Faculty of Medicine, University of Tsukuba

Division name

Department of Cardiovascular Surgery

Zip code

3058575

Address

1-1-1 Tennodai, Tsukuba, Ibaraki

TEL

029-853-3210

Homepage URL


Email

matsubaram@md.tsukuba.ac.jp


Sponsor or person

Institute

Department of Cardiovascular Surgery, Faculty of Medicine, University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Department of Cardiovascular Surgery, Faculty of Medicine, University of Tsukuba

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tsukuba Clinical Research Development Organization

Address

2-1-1,Amakubo,Tsukuba,Ibaraki

Tel

029-853-3914

Email

t-credo.adm@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 03 Month 16 Day

Date of IRB

2018 Year 03 Month 16 Day

Anticipated trial start date

2018 Year 06 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 05 Month 25 Day

Last modified on

2022 Year 11 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037311


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name